The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage?
about
Adaptation of HIV-1 depends on the host-cell environment.The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?Prevalence of and viral outcomes associated with primary HIV-1 drug resistancePrevalence of Transmitted Drug Resistance Mutations in HIV-1-Infected Drug-Naive Patients from Urban and Suburban Regions of Kenya.Bacterial pore-forming proteins as anthelmintics.Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have sex with men in Seattle/King County, WA, 2005-2007.
P2860
The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The challenge of antiretrovira ...... y possible clinical advantage?
@ast
The challenge of antiretrovira ...... y possible clinical advantage?
@en
type
label
The challenge of antiretrovira ...... y possible clinical advantage?
@ast
The challenge of antiretrovira ...... y possible clinical advantage?
@en
prefLabel
The challenge of antiretrovira ...... y possible clinical advantage?
@ast
The challenge of antiretrovira ...... y possible clinical advantage?
@en
P356
P1433
P1476
The challenge of antiretrovira ...... y possible clinical advantage?
@en
P2093
Mauro Zaccarelli
Valerio Tozzi
P304
P356
10.2174/1570162043351192
P577
2004-07-01T00:00:00Z